{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:45:32Z","timestamp":1759178732054},"reference-count":88,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:p>As in other organ systems, immunohistochemistry (IHC) serves as an ancillary diagnostic tool for a wide variety of neoplastic and non-neoplastic disorders, including infections, work-up of inflammatory conditions, and subtyping neoplasms of the gastrointestinal (GI) tract. In addition, IHC is also used to detect a variety of prognostic and predictive molecular biomarkers for carcinomas of the GI tract. The purpose of this review is to highlight the use of IHC in common diagnostic scenarios throughout the tubular GI tract. The clinical indication and guidelines for performing IHC for detecting <jats:italic toggle=\"yes\">Helicobacter pylori<\/jats:italic> is discussed along with role of gastrin and neuroendocrine markers in the diagnosis of autoimmune metaplastic atrophic gastritis. The major portion of this review discusses the use of IHC in the diagnostic workup of malignant neoplasms of the GI tract, such as adenocarcinoma versus squamous cell carcinoma, workup of poorly differentiated malignant neoplasms, and evaluation of uncommon gastric neoplasms (alpha-feto protein\u2013producing carcinomas) and switch\/sucrose-nonfermenting complex-deficient carcinomas. Lastly, localization of neuroendocrine tumors of unknown origin to aid clinical management, as well as HPV-driven anal neoplasia and IHC in the workup of basaloid anal neoplasms are also reviewed.<\/jats:p>","DOI":"10.1097\/pap.0000000000000214","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T20:36:04Z","timestamp":1537994164000},"page":"193-205","source":"Crossref","is-referenced-by-count":8,"title":["An Update on the Role of Immunohistochemistry in the Evaluation of Gastrointestinal Tract Disorders"],"prefix":"10.1097","volume":"27","author":[{"given":"Scott","family":"Robertson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepa T.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,9,18]]},"reference":[{"key":"R1-20230921","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","article-title":"Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994","volume":"20","author":"Dixon","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R2-20230921","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrgastro.2013.101","article-title":"Autoimmune atrophic gastritis\u2014pathogenesis, pathology and management","volume":"10","author":"Neumann","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R3-20230921","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/apt.12177","article-title":"Systematic review: gastric cancer incidence in pernicious anaemia","volume":"37","author":"Vannella","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"R4-20230921","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1111\/j.1572-0241.1999.01360.x","article-title":"Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis","volume":"94","author":"Eslick","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"R5-20230921","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1365-2036.2011.04659.x","article-title":"Development of type I gastric carcinoid in patients with chronic atrophic gastritis","volume":"33","author":"Vannella","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"R6-20230921","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/0140-6736(91)92035-Z","article-title":"Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma","volume":"338","author":"Wotherspoon","year":"1991","journal-title":"Lancet"},{"key":"R7-20230921","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jcp.49.2.107","article-title":"Detection of Helicobacter pylori in gastric biopsy and resection specimens","volume":"49","author":"Ashton-Key","year":"1996","journal-title":"J Clin Pathol"},{"key":"R8-20230921","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4103\/1319-3767.103428","article-title":"Correlation of serology with morphological changes in gastric biopsy in Helicobacter pylori infection and evaluation of immunohistochemistry for H. pylori identification","volume":"18","author":"Shukla","year":"2012","journal-title":"Saudi J Gastroenterol"},{"key":"R9-20230921","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1309\/AJCPD8FFBJ5LSLTE","article-title":"Are routine ancillary stains required to diagnose Helicobacter infection in gastric biopsy specimens? An institutional quality assurance review","volume":"137","author":"Hartman","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"R10-20230921","first-page":"36","article-title":"The immunohistochemistry and toluidine blue roles for Helicobacter pylori detection in patients with gastritis","volume":"17","author":"Tajalli","year":"2013","journal-title":"Iran Biomed J"},{"key":"R11-20230921","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/PAS.0b013e3181e51067","article-title":"Helicobacter pylori-negative gastritis: seek, yet ye shall not always find","volume":"34","author":"Genta","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R12-20230921","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1309\/AJCP0G6INEDBSXCN","article-title":"Upfront special staining for Helicobacter pylori in gastric biopsy specimens is not indicated","volume":"143","author":"Chitkara","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"R13-20230921","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/ajcp\/aqw149","article-title":"A strategy for Helicobacter immunohistochemistry utilization in pediatric practice. Insights from morphologic and cost-benefit analyses","volume":"146","author":"Conces","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"R14-20230921","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1097\/PAS.0000000000000654","article-title":"Do ancillary studies aid detection and classification of Barrett esophagus?","volume":"40","author":"Panarelli","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R15-20230921","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.dld.2015.04.005","article-title":"Helicobacter infections with rare bacteria or minimal gastritis: Expecting the unexpected","volume":"47","author":"Glickman","year":"2015","journal-title":"Dig Liver Dis"},{"key":"R16-20230921","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.humpath.2014.11.014","article-title":"Utility of ancillary stains for Helicobacter pylori in near-normal gastric biopsies","volume":"46","author":"Panarelli","year":"2015","journal-title":"Hum Pathol"},{"key":"R17-20230921","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PAS.0000000000000097","article-title":"Appropriate use of special stains for identifying Helicobacter pylori: recommendations from the Rodger C. Haggitt gastrointestinal pathology society","volume":"37","author":"Batts","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R18-20230921","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/PAT.0b013e32835cc22c","article-title":"Autoimmune gastritis: novel clues to histological diagnosis","volume":"45","author":"Bettington","year":"2013","journal-title":"Pathology"},{"key":"R19-20230921","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1097\/PAS.0000000000000481","article-title":"Autoimmune metaplastic atrophic gastritis: recognizing precursor lesions for appropriate patient evaluation","volume":"39","author":"Pittman","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R20-20230921","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/PAP.0b013e31828d185d","article-title":"Neuroendocrine proliferations of the stomach: a pragmatic approach for the perplexed pathologist","volume":"20","author":"Cockburn","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"R21-20230921","first-page":"S1","article-title":"Hyperplastic, dysplastic, and neoplastic enterochromaffin-like-cell proliferations of the gastric mucosa. Classification and histogenesis","volume":"19","author":"Solcia","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R22-20230921","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0959-8049(02)00008-4","article-title":"Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma","volume":"38","author":"Tot","year":"2002","journal-title":"Eur J Cancer"},{"key":"R23-20230921","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers10040108","article-title":"Immunohistochemistry for diagnosis of metastatic carcinomas of unknown primary site","volume":"10","author":"Selves","year":"2018","journal-title":"Cancers"},{"key":"R25-20230921","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.humpath.2012.03.019","article-title":"Immunohistochemical panel for distinguishing esophageal adenocarcinoma from squamous cell carcinoma: a combination of p63, cytokeratin 5\/6, MUC5AC, and anterior gradient homolog 2 allows optimal subtyping","volume":"43","author":"DiMaio","year":"2012","journal-title":"Hum Pathol"},{"key":"R26-20230921","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/PAS.0000000000000119","article-title":"Use of p40 and p63 immunohistochemistry and human papillomavirus testing as ancillary tools for the recognition of head and neck sarcomatoid carcinoma and its distinction from benign and malignant mesenchymal processes","volume":"38","author":"Bishop","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R27-20230921","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/modpathol.2011.173","article-title":"p40 (\u0394Np63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma","volume":"25","author":"Bishop","year":"2012","journal-title":"Mod Pathol"},{"key":"R28-20230921","first-page":"494","article-title":"p63 expression profiles in human normal and tumor tissues","volume":"8","author":"Di Como","year":"2002","journal-title":"Clin Cancer Res"},{"key":"R29-20230921","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/1066896913476750","article-title":"\u0394Np63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization","volume":"21","author":"Pelosi","year":"2013","journal-title":"Int J Surg Pathol"},{"key":"R30-20230921","first-page":"6855","article-title":"Esophagogastric junction carcinomas\u2014discriminating histological types through immunohistochemistry","volume":"37","author":"Mochizuki","year":"2017","journal-title":"Anticancer Res"},{"key":"R32-20230921","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000065838","article-title":"Clinicopathologic features of gastric cancers producing alpha-fetoprotein","volume":"19","author":"Kono","year":"2002","journal-title":"Dig Surg"},{"key":"R33-20230921","first-page":"321","article-title":"Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers","volume":"87","author":"Chang","year":"1992","journal-title":"Am J Gastroenterol"},{"key":"R34-20230921","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/jclinpath-2017-204535","article-title":"Fetal-type gastrointestinal adenocarcinoma\u202f: a morphologically distinct entity with unfavourable prognosis","volume":"71","author":"Arora","year":"2018","journal-title":"J Clin Pathol"},{"key":"R35-20230921","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/PAS.0b013e3181f0a873","article-title":"Analysis of clinicopathologic features and prognostic factors in hepatoid adenocarcinoma of the stomach","volume":"34","author":"Liu","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R36-20230921","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/PAS.0000000000000869","article-title":"Gastric cancer with primitive enterocyte phenotype","volume":"41","author":"Yamazawa","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R37-20230921","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1349-7006.2009.01108.x","article-title":"Glypican 3-expressing gastric carcinoma: distinct subgroup unifying hepatoid, clear-cell, and \u03b1-fetoprotein-producing gastric carcinomas","volume":"100","author":"Ushiku","year":"2009","journal-title":"Cancer Sci"},{"key":"R38-20230921","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.humpath.2016.04.008","article-title":"Arginase-1 is frequently positive in hepatoid adenocarcinomas","volume":"55","author":"Chandan","year":"2016","journal-title":"Hum Pathol"},{"key":"R39-20230921","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/PAS.0b013e3181d1dcdd","article-title":"SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma","volume":"34","author":"Ushiku","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R40-20230921","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.humpath.2011.11.022","article-title":"\u03b1-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression","volume":"43","author":"Ikeda","year":"2012","journal-title":"Hum Pathol"},{"key":"R41-20230921","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.cell.2006.05.012","article-title":"SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation","volume":"125","author":"Dobreva","year":"2006","journal-title":"Cell"},{"key":"R42-20230921","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1309\/AJCPWW2URZ9JKQJU","article-title":"The role of SATB2 as a diagnostic marker for tumors of colorectal origin: results of a pathology-based clinical prospective study","volume":"141","author":"Dragomir","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"R43-20230921","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/PAS.0b013e31821c3dae","article-title":"SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas","volume":"35","author":"Magnusson","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R44-20230921","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.5858\/arpa.2013-0452-OA","article-title":"Cadherin-17 and SATB2 are sensitive and specific immunomarkers for medullary carcinoma of the large intestine","volume":"138","author":"Lin","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"R45-20230921","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/00000478-200307000-00014","article-title":"Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve inoperative diagnosis","volume":"27","author":"Seidman","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R46-20230921","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/PAS.0b013e3180690d2d","article-title":"Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification","volume":"32","author":"Yemelyanova","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R47-20230921","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.pas.0000213281.43036.bb","article-title":"Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases","volume":"30","author":"Vang","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R48-20230921","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/modpathol.3800698","article-title":"Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7","volume":"19","author":"Vang","year":"2006","journal-title":"Mod Pathol"},{"key":"R49-20230921","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/his.12899","article-title":"Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT-rich sequence-binding protein 2 in their distinction from primary ovarian mucinous tumours","volume":"68","author":"Strickland","year":"2016","journal-title":"Histopathology"},{"key":"R50-20230921","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/PGP.0000000000000238","article-title":"Immunohistochemistry in the diagnosis of mucinous neoplasms involving the ovary: the added value of SATB2 and biomarker discovery through protein expression database mining","volume":"35","author":"Strickland","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"R51-20230921","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/PAS.0000000000000553","article-title":"SATB2 expression distinguishes ovarian metastases of colorectal and appendiceal origin from primary ovarian tumors of mucinous or endometrioid type","volume":"40","author":"Moh","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R52-20230921","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/PAS.0b013e31816b18c1","article-title":"Primary ovarian mucinous tumors with signet ring cells: report of 3 cases with discussion of so-called primary krukenberg tumor","volume":"32","author":"McCluggage","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R53-20230921","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.pas.0000190787.85024.cb","article-title":"Krukenberg tumors of the ovary: a clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations","volume":"30","author":"Kiyokawa","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R54-20230921","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/PAS.0000000000000951","article-title":"Diagnostic utility of SATB2 in metastatic Krukenberg tumors of the ovary: an immunohistochemical study of 70 cases with comparison to CDX2, CK7, CK20, chromogranin, and synaptophysin","volume":"42","author":"Yang","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R55-20230921","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/ajmg.c.31410","article-title":"SWI\/SNF chromatin remodeling complexes and cancer","volume":"166","author":"Biegel","year":"2014","journal-title":"Am J Med Genet Part C Semin Med Genet"},{"key":"R56-20230921","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/PAS.0b013e31822b325b","article-title":"INI1-deficient tumors","volume":"35","author":"Hollmann","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R57-20230921","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/PAS.0000000000000554","article-title":"SWI\/SNF complex-deficient undifferentiated\/rhabdoid carcinomas of the gastrointestinal tract: a series of 13 cases highlighting mutually exclusive loss of SMARCA4 and SMARCA2 and frequent co-inactivation of SMARCB1 and SMARCA2","volume":"40","author":"Agaimy","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R58-20230921","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/PAS.0000000000000173","article-title":"SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review","volume":"38","author":"Agaimy","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R59-20230921","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1038\/modpathol.2010.166","article-title":"The origin of neuroendocrine tumors and the neural crest saga","volume":"24","author":"Rosai","year":"2011","journal-title":"Mod Pathol"},{"key":"R61-20230921","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/01.sla.0000164073.08093.5d","article-title":"Surgical treatment of advanced-stage carcinoid tumors: lessons learned","volume":"241","author":"Boudreaux","year":"2005","journal-title":"Ann Surg"},{"key":"R62-20230921","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.surg.2006.07.033","article-title":"Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survival","volume":"140","author":"Givi","year":"2006","journal-title":"Surgery"},{"key":"R63-20230921","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1072-7515(98)00099-4","article-title":"Isolated liver metastases from neuroendocrine tumors: does resection prolong survival?","volume":"187","author":"Chen","year":"1998","journal-title":"J Am Coll Surg"},{"key":"R64-20230921","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/archsurg.2010.10","article-title":"Identification of unknown primary tumors in patients with neuroendocrine liver metastases","volume":"145","author":"Wang","year":"2010","journal-title":"Arch Surg"},{"key":"R65-20230921","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1385\/EP:15:3:247","article-title":"Cdx2 as a marker for neuroendocrine tumors of unknown primary sites","volume":"15","author":"Erickson","year":"2004","journal-title":"Endocr Pathol"},{"key":"R66-20230921","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/modpathol.2012.34","article-title":"Value of Islet 1 and PAX8 in identifying metastatic neuroendocrine tumors of pancreatic origin","volume":"25","author":"Koo","year":"2012","journal-title":"Mod Pathol"},{"key":"R67-20230921","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/PAS.0b013e318158a397","article-title":"Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases","volume":"32","author":"Schmitt","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R68-20230921","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/PAS.0b013e31818d7d8b","article-title":"Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors","volume":"33","author":"Srivastava","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R69-20230921","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/PAP.0b013e3182a2dc67","article-title":"Assigning site of origin in metastatic neuroendocrine neoplasms: a clinically significant application of diagnostic immunohistochemistry","volume":"20","author":"Bellizzi","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"R70-20230921","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/PAS.0b013e31824aba59","article-title":"PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms","volume":"36","author":"Chan","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R71-20230921","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.humpath.2004.02.016","article-title":"TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location","volume":"35","author":"Du","year":"2004","journal-title":"Hum Pathol"},{"key":"R72-20230921","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/modpathol.3800105","article-title":"Thyroid transcription factor-1, but not p53, is helpful in distinguishing moderately differentiated neuroendocrine carcinoma of the larynx from medullary carcinoma of the thyroid","volume":"17","author":"Hirsch","year":"2004","journal-title":"Mod Pathol"},{"key":"R73-20230921","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/344879a0","article-title":"Insulin gene enhancer binding protein Isl-1 is a member of a novel class of proteins containing both a homeo-and a Cys-His domain","volume":"344","author":"Karlsson","year":"1990","journal-title":"Nature"},{"key":"R74-20230921","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/PAS.0000000000000876","article-title":"Immunohistochemical characterization of the origins of metastatic well-differentiated neuroendocrine tumors to the liver","volume":"41","author":"Yang","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R75-20230921","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/PAS.0b013e31826f042c","article-title":"Islet-1 is a sensitive but not entirely specific marker for pancreatic neuroendocrine neoplasms and their metastases","volume":"37","author":"Graham","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R76-20230921","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/modpathol.2013.40","article-title":"ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin","volume":"26","author":"Agaimy","year":"2013","journal-title":"Mod Pathol"},{"key":"R77-20230921","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/modpathol.2011.3","article-title":"PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study","volume":"24","author":"Ozcan","year":"2011","journal-title":"Mod Pathol"},{"key":"R78-20230921","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/PAS.0b013e3181da0a20","article-title":"PAX8 expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors","volume":"34","author":"Long","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R79-20230921","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/modpathol.2010.176","article-title":"PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma","volume":"24","author":"Sangoi","year":"2011","journal-title":"Mod Pathol"},{"key":"R80-20230921","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/PAI.0000000000000149","article-title":"The diagnostic utility of PAX8 for neuroendocrine tumors: an immunohistochemical reappraisal","volume":"24","author":"Liau","year":"2016","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R81-20230921","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/modpathol.2011.162","article-title":"N-terminal PAX8 polyclonal antibody shows cross-reactivity with N-terminal region of PAX5 and is responsible for reports of PAX8 positivity in malignant lymphomas","volume":"25","author":"Moretti","year":"2012","journal-title":"Mod Pathol"},{"key":"R82-20230921","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00418-011-0866-3","article-title":"Immunohistochemical assessment of Pax8 expression during pancreatic islet development and in human neuroendocrine tumors","volume":"136","author":"Lorenzo","year":"2011","journal-title":"Histochem Cell Biol"},{"key":"R84-20230921","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.humpath.2005.04.007","article-title":"Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases","volume":"36","author":"Jones","year":"2005","journal-title":"Hum Pathol"},{"key":"R85-20230921","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/PAS.0b013e31826d2639","article-title":"Primary high-grade neuroendocrine carcinoma of the esophagus: a clinicopathologic and immunohistochemical study of 42 resection cases","volume":"37","author":"Huang","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R86-20230921","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/00000478-200606000-00005","article-title":"Small cell carcinoma of the prostate: an immunohistochemical study","volume":"30","author":"Yao","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R87-20230921","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/jcp.2010.077024","article-title":"Small cell carcinomas in gastrointestinal tract: immunohistochemical and clinicopathological features","volume":"63","author":"Li","year":"2010","journal-title":"J Clin Pathol"},{"key":"R88-20230921","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/his.12278","article-title":"BAI3, CDX2 and VIL1: a panel of three antibodies to distinguish small cell from large cell neuroendocrine lung carcinomas","volume":"64","author":"Bari","year":"2014","journal-title":"Histopathology"},{"key":"R89-20230921","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.5858\/arpa.LGT200570","article-title":"The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology","volume":"136","author":"Darragh","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"R90-20230921","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/s41379-018-0026-6","article-title":"p16 immunostaining in histological grading of anal squamous intraepithelial lesions: a systematic review and meta-analysis","volume":"31","author":"Albuquerque","year":"2018","journal-title":"Mod Pathol"},{"key":"R91-20230921","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/PAS.0000000000000858","article-title":"The impact of p16 immunostaining in reducing anal squamous intraepithelial lesions indication for treatment","volume":"41","author":"Albuquerque","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R92-20230921","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/modpathol.2013.75","article-title":"Clinicopathological analysis of basal cell carcinoma of the anal region and its distinction from basaloid squamous cell carcinoma","volume":"26","author":"Patil","year":"2013","journal-title":"Mod Pathol"}],"container-title":["Advances in Anatomic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAP.0000000000000214","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T18:32:56Z","timestamp":1695321176000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAP.0000000000000214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,18]]},"references-count":88,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pap.0000000000000214","relation":{},"ISSN":["1072-4109"],"issn-type":[{"value":"1072-4109","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,18]]}}}